600566 濟川藥業
按盤價 
32.540 +0.120 (+0.370%) | 2024/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 5,805,135 | -11.19% | 9,654,537 | 8,996,367 | 7,630,510 | 6,164,974 | |
| 減：營業總成本 | 3,879,965 | -12.97% | 6,516,458 | 6,620,728 | 5,862,687 | 4,725,475 | |
| 其中:營業成本 | 1,204,123 | 0.63% | 1,783,993 | 1,537,411 | 1,276,564 | 1,130,254 | |
| 財務費用 | (205,391) | 20.60% | (257,489) | (85,763) | (88,966) | (48,074) | |
| 資產減值損失 | -- | -- | -- | -- | -- | -- | |
| 公允價值變動收益 | 86,459 | 456.47% | 14,604 | (7,316) | 114,554 | 20,942 | |
| 投資收益 | 30,728 | -59.91% | 81,724 | 66,209 | 46,978 | 1,366 | |
| 其中：對聯營企業和合營企業的投資收益 | -- | -- | 2,457 | 769 | 675 | (245) | |
| 營業利潤 | 2,119,658 | -4.72% | 3,258,136 | 2,423,498 | 1,932,826 | 1,468,965 | |
| 利潤總額 | 2,233,498 | -1.15% | 3,297,090 | 2,507,921 | 1,950,435 | 1,483,506 | |
| 減：所得稅費用 | 326,152 | 4.47% | 470,027 | 336,202 | 233,219 | 206,294 | |
| 淨利潤 | 1,907,346 | -2.06% | 2,827,063 | 2,171,719 | 1,717,216 | 1,277,212 | |
| 減：非控股權益 | 4,517 | 40.18% | 4,282 | 969 | (1,959) | -- | |
| 股東淨利潤 | 1,902,830 | -2.13% | 2,822,781 | 2,170,750 | 1,719,176 | 1,277,212 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 2.071 | -2.45% | 3.080 | 2.440 | 1.940 | 1.530 | |
| 每股派息 (元) * | -- | -- | 1.300 | 0.880 | 0.680 | 0.450 | |
| 每股淨資產 (元) * | 15.267 | 12.92% | 14.482 | 12.299 | 10.150 | 8.626 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 08/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
